查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1699185

人工智慧药物研发市场分析及2034年预测：类型、产品、服务、技术、组件、应用、部署、最终用户、阶段

Artificial Intelligence for Drug Discovery Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Deployment, End User, Stage
出版日期: | 出版商: Global Insight Services | 英文 417 Pages | 商品交期: 3-5个工作天内

价格
简介目录

药物研发中的人工智慧市场预计将从 2024 年的 63 亿美元成长到 2034 年的 165 亿美元，复合年增长率约为 10.1%。该市场涵盖了人工智慧技术在药物研究中的整合，旨在简化药物开发流程。该市场专注于利用机器学习、深度学习和资料分析来增强目标识别、分子筛检和预测模型。对具有成本效益和高效的药物发现解决方案的日益增长的需求正在推动人工智慧主导平台的进步，鼓励科技公司和製药公司之间的合作，并鼓励采用人工智慧的法规结构。

市场概览

药物发现的人工智慧市场发展迅速，主要分为药物优化和再利用、临床前测试和临床试验设计。其中，药物优化和再利用是由对具有成本效益和时间效率的药物开发过程的需求所驱动。该领域占据主导地位的原因是该行业越来越依赖人工智慧来提高药物疗效预测的准确性并缩短新治疗方法的上市时间。机器学习演算法和神经网路等技术的进步促进了海量资料集的分析，从而实现了精确的药物-标靶相互作用。个人化医疗和人工智慧主导的生物标记发现等新的子区隔越来越受欢迎。这些子区隔有望彻底改变针对患者的护理并提高治疗性介入的精确度。随着这些技术的成熟，它们有望透过提高药物发现的成功率和刺激个人化医疗解决方案的创新对市场产生重大影响。

市场区隔
类型 小分子、生技药品、疫苗、胜肽、抗体、核酸
产品 软体、平台、工具、资料库
服务 咨询、实施、整合、维护、培训和支持
科技 机器学习、深度学习、自然语言处理、电脑视觉
成分 硬体、软体和服务
应用 标靶辨识、分子筛检、先导药物最适化、临床前测试、临床试验
扩张 云端基础、本地、混合
最终用户 製药公司、生技公司、研究机构、委外研发机构
步 药物发现、临床前、临床、核准

受对更高效的药物开发流程的需求不断增长的推动，机器学习平台和软体解决方案在药物研发市场的人工智慧领域占据主导地位。这一趋势进一步受到製药业日益依赖人工智慧技术来提高药物疗效和缩短上市时间的推动。从地区来看，北美在药物研发中采用人工智慧方面处于领先地位，而欧洲和亚太地区在人工智慧主导的医疗创新方面取得了重大进展并投入了巨额资金。竞争格局包括Google、微软和 IBM 等主要参与企业，他们不断创新以保持竞争力。北美和欧洲等地区的法规结构对于塑造市场动态至关重要，特别是透过鼓励创新同时确保病患安全的措施。人工智慧在药物研发领域的前景光明，预计随着人工智慧演算法和运算能力的进步，其成长将会加速。然而，挑战依然存在，例如对资料隐私的担忧以及对人工智慧模型进行严格检验的需求。儘管存在这些障碍，但人工智慧和量子运算等新兴技术的整合有望开闢药物发现的新前沿，并为市场扩张提供机会。

主要趋势和驱动因素

由于几个关键趋势和驱动因素，药物研发市场的人工智慧正在经历显着成长。一个关键趋势是人工智慧和巨量资料分析的日益融合，实现更精确的药物发现过程。这种整合增强了分析复杂生物资料集的能力，加速了潜在候选药物的辨识。另一个趋势是製药公司与人工智慧技术公司的合作日益增多。这些伙伴关係促进了创新并加速了药物开发进程。此外，个人化医疗的需求日益增长，而人工智慧具有独特的优势，可以根据个人的基因特征量身定制治疗方案。市场迫切需要减少与传统药物研发方法相关的时间和成本。事实证明，人工智慧可以简化流程并提高效率。此外，慢性病的增加使得开发新的有效治疗方法成为必要，这进一步推动了人工智慧在药物研发中的应用。随着各机构认识到人工智慧改变药物开发的潜力，法规环境也正在改善。

限制与挑战

药物研发市场的人工智慧面临一些重大的限制和挑战。一个关键的挑战是将人工智慧技术融入现有的製药工作流程，这通常需要大量的时间和资源投入。此外，监管障碍也是一个重大障碍，因为基于人工智慧的药物研发工具的核准过程漫长而复杂。此外，开发和部署人工智慧解决方案的高成本可能会阻碍中小企业进入市场。资料隐私问题，尤其是有关病患资料问题也是一个障碍，因为严格的法规要求采取强而有力的安全措施。最后，缺乏能够有效弥合人工智慧技术与製药应用之间差距的熟练专业人员，限制了创新的步伐。儘管人工智慧有望改变整个产业，但这些因素共同阻碍了其在药物研发领域的快速应用和扩展。

目录

第一章 药物研发市场人工智慧概述

  • 研究目标
  • 药物研发中人工智慧的定义与范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章重要考察

第四章 人工智慧在药物研发的前景

  • 药物研发中人工智慧的细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章 药物研发中的人工智慧策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 使用案例分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析

第六章 药物研发中人工智慧的市场规模

  • 药物研发人工智慧市场规模（以价值计算）
  • 药物研发中的人工智慧市场规模（以数量计算）

第七章.药物研发市场中的人工智慧（按类型）

  • 市场概览
  • 小分子化合物
  • 生技药品
  • 疫苗
  • 胜肽
  • 抗体
  • 核酸
  • 其他的

第八章药物研发市场的人工智慧（按产品）

  • 市场概览
  • 软体
  • 平台
  • 工具
  • 资料库
  • 其他的

第九章药物研发市场中的人工智慧（按服务）

  • 市场概览
  • 咨询
  • 执行
  • 一体化
  • 维护
  • 训练
  • 支援
  • 其他的

第十章 药物研发市场中的人工智慧（按技术）

  • 市场概览
  • 机器学习
  • 深度学习
  • 自然语言处理
  • 电脑视觉
  • 其他的

第 11 章。药物研发市场中的人工智慧（按组成部分）

  • 市场概览
  • 硬体
  • 软体
  • 服务
  • 其他的

第 12 章人工智慧在药物研发市场的应用

  • 市场概览
  • 目标识别
  • 分子筛检
  • 先导化合物优化
  • 临床前测试
  • 实验室测试
  • 其他的

第十三章药物研发市场中的人工智慧（按部署）

  • 市场概览
  • 云端基础
  • 本地
  • 杂交种
  • 其他的

第 14 章。药物研发市场中的人工智慧（按最终用户）

  • 市场概览
  • 製药公司
  • 生技公司
  • 研究所
  • 受託研究机构
  • 其他的

第十五章 药物研发市场中的人工智慧（依阶段）

  • 市场概览
  • 药物研发
  • 临床前
  • 实验室测试
  • 核准
  • 其他的

第十六章 药物研发人工智慧市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市场占有率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章 公司简介

  • Insilico Medicine
  • Exscientia
  • BenevolentAI
  • Atomwise
  • Recursion Pharmaceuticals
  • Schrodinger
  • Cyclica
  • BioSymetrics
  • Verge Genomics
  • XtalPi
  • Deep Genomics
  • Valo Health
  • TwoXAR
  • Numerate
  • Cloud Pharmaceuticals
  • Aria Pharmaceuticals
  • PathAI
  • Peptone
  • Healx
  • InveniAI
简介目录
Product Code: GIS32611

Artificial Intelligence for Drug Discovery Market is anticipated to expand from $6.3 billion in 2024 to $16.5 billion by 2034, growing at a CAGR of approximately 10.1%. The market encompasses the integration of AI technologies in pharmaceutical research, aiming to streamline drug development processes. This market focuses on leveraging machine learning, deep learning, and data analytics to enhance target identification, molecular screening, and predictive modeling. The growing need for cost-effective and efficient drug discovery solutions is propelling advancements in AI-driven platforms, fostering collaborations between tech firms and pharmaceutical companies, and encouraging regulatory frameworks for AI adoption.

Market Overview:

The Artificial Intelligence for Drug Discovery Market is evolving rapidly, segmented primarily into drug optimization and repurposing, preclinical testing, and clinical trial design. Of these, drug optimization and repurposing lead the market, driven by the need for cost-effective and time-efficient drug development processes. This segment's dominance is attributed to the industry's growing reliance on AI to enhance the accuracy of drug efficacy predictions and reduce the time-to-market for new therapies. Technological advancements, such as machine learning algorithms and neural networks, facilitate the analysis of vast datasets, enabling precise drug-target interactions. Emerging sub-segments, like personalized medicine and AI-driven biomarker discovery, are gaining traction. These sub-segments promise to revolutionize patient-specific treatments and enhance the precision of therapeutic interventions. As these technologies mature, they are expected to significantly impact the market by improving the success rates of drug discovery and fostering innovation in personalized healthcare solutions.

Market Segmentation
TypeSmall Molecule, Biologics, Vaccines, Peptides, Antibodies, Nucleic Acids
ProductSoftware, Platform, Tools, Databases
ServicesConsulting, Implementation, Integration, Maintenance, Training, Support
TechnologyMachine Learning, Deep Learning, Natural Language Processing, Computer Vision
ComponentHardware, Software, Services
ApplicationTarget Identification, Molecule Screening, Lead Optimization, Preclinical Testing, Clinical Trials
DeploymentCloud-Based, On-Premise, Hybrid
End UserPharmaceutical Companies, Biotechnology Firms, Research Institutes, Contract Research Organizations
StageDiscovery, Preclinical, Clinical, Approval

Machine learning platforms and software solutions dominate the artificial intelligence for drug discovery market, propelled by the increasing demand for more efficient drug development processes. The pharmaceutical sector's growing reliance on AI technologies to enhance drug efficacy and reduce time-to-market further bolsters this trend. Geographically, North America leads in AI adoption within drug discovery, while Europe and Asia-Pacific are witnessing significant advancements and investments in AI-driven healthcare innovations. The competitive landscape is marked by the presence of key players such as Google, Microsoft, and IBM, who are continually innovating to maintain their competitive edge. Regulatory frameworks in regions like North America and Europe are pivotal in shaping the market dynamics, particularly through policies that encourage innovation while ensuring patient safety. The future of AI in drug discovery is promising, with projections indicating accelerated growth driven by advancements in AI algorithms and computational power. However, challenges such as data privacy concerns and the need for robust validation of AI models persist. Despite these hurdles, the integration of AI with emerging technologies like quantum computing is expected to unlock new frontiers in drug discovery, presenting lucrative opportunities for market expansion.

Geographical Overview:

The Artificial Intelligence for Drug Discovery market is witnessing robust growth across various regions, each exhibiting unique characteristics. North America leads the charge, buoyed by substantial investments in AI technologies and a strong pharmaceutical sector. The presence of key industry players and academic institutions accelerates innovation, making the region a powerhouse in AI-driven drug discovery. Europe follows as a formidable contender, with its commitment to cutting-edge research and development. The region's stringent regulatory framework ensures high-quality outcomes, fostering trust and reliability in AI applications for drug discovery. Collaborative efforts between public and private sectors further bolster Europe's position. In Asia Pacific, the market is expanding rapidly, propelled by significant technological advancements and a burgeoning healthcare sector. Countries like China and India are investing heavily in AI initiatives, aiming to revolutionize drug discovery processes. This surge is supported by government policies and a growing pool of skilled professionals. Latin America is emerging as a promising market, with increasing investments in AI infrastructure and a focus on innovative healthcare solutions. The region's potential is being unlocked through strategic partnerships and government support, paving the way for future growth. The Middle East & Africa are recognizing the transformative power of AI in drug discovery. Investments in AI technologies are on the rise, driven by the need to enhance healthcare outcomes and foster economic development. These regions are poised to capitalize on AI's capabilities to address local healthcare challenges.

Recent Development:

The Artificial Intelligence for Drug Discovery Market has witnessed significant developments over the past three months. Firstly, Pfizer announced a strategic partnership with a leading AI firm to accelerate its drug discovery processes, highlighting the growing trend of pharmaceutical companies integrating AI technologies. Secondly, Roche entered into a joint venture with an AI start-up, focusing on leveraging machine learning to identify novel drug candidates, aiming to streamline and enhance their R&D efforts. Thirdly, AstraZeneca reported a major breakthrough using AI algorithms in identifying potential treatments for rare diseases, underscoring the transformative potential of AI in addressing unmet medical needs. Fourthly, a significant merger was announced between two AI-driven biotech firms, creating a powerhouse poised to innovate in the drug discovery space. Lastly, regulatory bodies in the European Union introduced new guidelines to ensure ethical AI use in drug discovery, emphasizing the importance of transparency and accountability in this burgeoning field. These developments underscore the dynamic and rapidly evolving nature of the AI for Drug Discovery Market.

Key Trends and Drivers:

The Artificial Intelligence for Drug Discovery Market is experiencing substantial growth due to several key trends and drivers. A significant trend is the increasing integration of AI with big data analytics, enabling more precise drug discovery processes. This integration is enhancing the ability to analyze complex biological data sets, thereby accelerating the identification of potential drug candidates. Another trend is the growing collaboration between pharmaceutical companies and AI technology firms. These partnerships are fostering innovation and speeding up the drug development pipeline. Additionally, there is a rising demand for personalized medicine, which AI is uniquely positioned to support by tailoring treatments to individual genetic profiles. Drivers of this market include the urgent need to reduce the time and cost associated with traditional drug discovery methods. AI offers a solution by streamlining processes and improving efficiency. Furthermore, the increasing prevalence of chronic diseases necessitates the development of new and effective therapies, further propelling the adoption of AI in drug discovery. The regulatory environment is also becoming more favorable, with agencies recognizing the potential of AI to transform drug development.

Restraints and Challenges:

The Artificial Intelligence for Drug Discovery Market encounters several critical restraints and challenges. A primary challenge is the integration of AI technologies into existing pharmaceutical workflows, which often requires substantial time and resource investment. Regulatory hurdles also pose significant barriers, as the approval processes for AI-driven drug discovery tools can be lengthy and complex. Furthermore, the high costs associated with developing and implementing AI solutions may deter smaller companies from entering the market. Data privacy concerns, particularly regarding patient data, present another obstacle, as stringent regulations necessitate robust security measures. Lastly, there is a shortage of skilled professionals who can effectively bridge the gap between AI technology and pharmaceutical applications, limiting the pace of innovation. These factors collectively impede the rapid adoption and expansion of AI in drug discovery, despite its promising potential to revolutionize the industry.

Key Companies:

Insilico Medicine, Exscientia, Benevolent AI, Atomwise, Recursion Pharmaceuticals, Schrodinger, Cyclica, Bio Symetrics, Verge Genomics, Xtal Pi, Deep Genomics, Valo Health, Two XAR, Numerate, Cloud Pharmaceuticals, Aria Pharmaceuticals, Path AI, Peptone, Healx, Inveni AI

Sources:

National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), National Center for Biotechnology Information (NCBI), European Bioinformatics Institute (EMBL-EBI), National Science Foundation (NSF), U.S. Department of Health and Human Services (HHS), Health Canada, Biotechnology and Biological Sciences Research Council (BBSRC), The Francis Crick Institute, Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL), Stanford University - Institute for Computational and Mathematical Engineering, University of Oxford - Department of Statistics, Harvard University - Department of Biomedical Informatics, International Conference on Intelligent Systems for Molecular Biology (ISMB), Conference on Artificial Intelligence in Medicine (AIME), American Association for Cancer Research (AACR) Annual Meeting, Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition, Bio-IT World Conference & Expo

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Artificial Intelligence for Drug Discovery Overview

  • 1.1 Objectives of the Study
  • 1.2 Artificial Intelligence for Drug Discovery Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by End User
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by End User
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Artificial Intelligence for Drug Discovery Outlook

  • 4.1 Artificial Intelligence for Drug Discovery Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Artificial Intelligence for Drug Discovery Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Artificial Intelligence for Drug Discovery Size

  • 6.1 Artificial Intelligence for Drug Discovery Size, by Value
  • 6.2 Artificial Intelligence for Drug Discovery Size, by Volume

7: Artificial Intelligence for Drug Discovery, by Type

  • 7.1 Market Overview
  • 7.2 Small Molecule
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Biologics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Vaccines
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Peptides
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Antibodies
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Nucleic Acids
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Others
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region

8: Artificial Intelligence for Drug Discovery, by Product

  • 8.1 Market Overview
  • 8.2 Software
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Platform
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Tools
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Databases
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Artificial Intelligence for Drug Discovery, by Services

  • 9.1 Market Overview
  • 9.2 Consulting
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Implementation
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Integration
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Maintenance
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Training
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Support
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Artificial Intelligence for Drug Discovery, by Technology

  • 10.1 Market Overview
  • 10.2 Machine Learning
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Deep Learning
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Natural Language Processing
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Computer Vision
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Artificial Intelligence for Drug Discovery, by Component

  • 11.1 Market Overview
  • 11.2 Hardware
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Software
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Services
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Artificial Intelligence for Drug Discovery, by Application

  • 12.1 Market Overview
  • 12.2 Target Identification
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Molecule Screening
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Lead Optimization
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Preclinical Testing
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Clinical Trials
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Artificial Intelligence for Drug Discovery, by Deployment

  • 13.1 Market Overview
  • 13.2 Cloud-Based
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 On-Premise
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Hybrid
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Artificial Intelligence for Drug Discovery, by End User

  • 14.1 Market Overview
  • 14.2 Pharmaceutical Companies
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Biotechnology Firms
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Research Institutes
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Contract Research Organizations
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Artificial Intelligence for Drug Discovery, by Stage

  • 15.1 Market Overview
  • 15.2 Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Preclinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Clinical
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Approval
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: Artificial Intelligence for Drug Discovery, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by Deployment
    • 16.2.9 North America Market Size and Forecast, by End User
    • 16.2.10 North America Market Size and Forecast, by Stage
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by Deployment
      • 16.2.9.8 United States Market Size and Forecast, by End User
      • 16.2.9.9 United States Market Size and Forecast, by Stage
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by Deployment
      • 16.2.10.8 Canada Market Size and Forecast, by End User
      • 16.2.10.9 Canada Market Size and Forecast, by Stage
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by Deployment
    • 16.3.9 Europe Market Size and Forecast, by End User
    • 16.3.10 Europe Market Size and Forecast, by Stage
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 16.3.9.8 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by Deployment
      • 16.3.10.8 Germany Market Size and Forecast, by End User
      • 16.3.10.9 Germany Market Size and Forecast, by Stage
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by Deployment
      • 16.3.11.8 France Market Size and Forecast, by End User
      • 16.3.11.9 France Market Size and Forecast, by Stage
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by Deployment
      • 16.3.12.8 Spain Market Size and Forecast, by End User
      • 16.3.12.9 Spain Market Size and Forecast, by Stage
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by Deployment
      • 16.3.13.8 Italy Market Size and Forecast, by End User
      • 16.3.13.9 Italy Market Size and Forecast, by Stage
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 16.3.14.8 Netherlands Market Size and Forecast, by End User
      • 16.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 16.3.15.8 Sweden Market Size and Forecast, by End User
      • 16.3.15.9 Sweden Market Size and Forecast, by Stage
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 16.3.16.8 Switzerland Market Size and Forecast, by End User
      • 16.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 16.3.17.8 Denmark Market Size and Forecast, by End User
      • 16.3.17.9 Denmark Market Size and Forecast, by Stage
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by Deployment
      • 16.3.18.8 Finland Market Size and Forecast, by End User
      • 16.3.18.9 Finland Market Size and Forecast, by Stage
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by Deployment
      • 16.3.19.8 Russia Market Size and Forecast, by End User
      • 16.3.19.9 Russia Market Size and Forecast, by Stage
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 16.4.9 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by Deployment
      • 16.4.9.8 China Market Size and Forecast, by End User
      • 16.4.9.9 China Market Size and Forecast, by Stage
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by Deployment
      • 16.4.10.8 India Market Size and Forecast, by End User
      • 16.4.10.9 India Market Size and Forecast, by Stage
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by Deployment
      • 16.4.11.8 Japan Market Size and Forecast, by End User
      • 16.4.11.9 Japan Market Size and Forecast, by Stage
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 16.4.12.8 South Korea Market Size and Forecast, by End User
      • 16.4.12.9 South Korea Market Size and Forecast, by Stage
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by Deployment
      • 16.4.13.8 Australia Market Size and Forecast, by End User
      • 16.4.13.9 Australia Market Size and Forecast, by Stage
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 16.4.14.8 Singapore Market Size and Forecast, by End User
      • 16.4.14.9 Singapore Market Size and Forecast, by Stage
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 16.4.15.8 Indonesia Market Size and Forecast, by End User
      • 16.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 16.4.16.8 Taiwan Market Size and Forecast, by End User
      • 16.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 16.4.17.8 Malaysia Market Size and Forecast, by End User
      • 16.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by Deployment
    • 16.5.9 Latin America Market Size and Forecast, by End User
    • 16.5.10 Latin America Market Size and Forecast, by Stage
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 16.5.9.8 Brazil Market Size and Forecast, by End User
      • 16.5.9.9 Brazil Market Size and Forecast, by Stage
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 16.5.10.8 Mexico Market Size and Forecast, by End User
      • 16.5.10.9 Mexico Market Size and Forecast, by Stage
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 16.5.11.8 Argentina Market Size and Forecast, by End User
      • 16.5.11.9 Argentina Market Size and Forecast, by Stage
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 16.6.9 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by Deployment
      • 16.6.10.8 UAE Market Size and Forecast, by End User
      • 16.6.10.9 UAE Market Size and Forecast, by Stage
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 16.6.11.8 South Africa Market Size and Forecast, by End User
      • 16.6.11.9 South Africa Market Size and Forecast, by Stage
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Insilico Medicine
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Exscientia
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 BenevolentAI
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Atomwise
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Recursion Pharmaceuticals
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Schrodinger
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Cyclica
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 BioSymetrics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Verge Genomics
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 XtalPi
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Deep Genomics
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Valo Health
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 TwoXAR
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Numerate
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Cloud Pharmaceuticals
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
  • 18.16 Aria Pharmaceuticals
    • 18.16.1 Company Overview
    • 18.16.2 Company Snapshot
    • 18.16.3 Business Segments
    • 18.16.4 Business Performance
    • 18.16.5 Product Offerings
    • 18.16.6 Key Developmental Strategies
    • 18.16.7 SWOT Analysis
  • 18.17 PathAI
    • 18.17.1 Company Overview
    • 18.17.2 Company Snapshot
    • 18.17.3 Business Segments
    • 18.17.4 Business Performance
    • 18.17.5 Product Offerings
    • 18.17.6 Key Developmental Strategies
    • 18.17.7 SWOT Analysis
  • 18.18 Peptone
    • 18.18.1 Company Overview
    • 18.18.2 Company Snapshot
    • 18.18.3 Business Segments
    • 18.18.4 Business Performance
    • 18.18.5 Product Offerings
    • 18.18.6 Key Developmental Strategies
    • 18.18.7 SWOT Analysis
  • 18.19 Healx
    • 18.19.1 Company Overview
    • 18.19.2 Company Snapshot
    • 18.19.3 Business Segments
    • 18.19.4 Business Performance
    • 18.19.5 Product Offerings
    • 18.19.6 Key Developmental Strategies
    • 18.19.7 SWOT Analysis
  • 18.20 InveniAI
    • 18.20.1 Company Overview
    • 18.20.2 Company Snapshot
    • 18.20.3 Business Segments
    • 18.20.4 Business Performance
    • 18.20.5 Product Offerings
    • 18.20.6 Key Developmental Strategies
    • 18.20.7 SWOT Analysis